Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates
Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates
复制标题
DOI:
10.1073/pnas.0405621102
复制
发表时间:
2005-01-18
影响因子:
11.1
通讯作者:
Dawson, GR
中科院分区:
文献类型:
--
作者:
Rowlett, JK;Platt, DM;Dawson, GR
Benzodiazepines exert their effects by binding to multiple subtypes of the GABA(A) receptor, the predominant subtypes in the brain being those that contain alpha(1)-, alpha(2)-, alpha(3)-, and alpha(5)-subunits. To understand the potentially different roles of these subtypes in the therapeutic and side effects of benzodiazepines, we evaluated GABA(A) receptor subtype-pref erring compounds in nonhuman primate models predictive of anxiolytic, sedative, motor, subjective, and reinforcing effects of benzodiazepine-type drugs. These compounds included zolpidem, which shows preferential binding to GABA(A) receptors containing alpha(1)-subunits (alpha(1)GABA(A) receptors); L-838,417, which shows functional selectivity for alpha(2)GABA(A), alpha(3)GABA(A), and alpha(5)GABA(A) receptors; and nonselective conventional benzodiazepines. The results provide evidence in nonhuman primates that alpha(1)GABA(A) receptors do not play a key role in the anxiolytic and muscle-relaxant properties of benzodiazepine-type drugs; instead, these effects involve alpha(2)GABA(A), alpha(3)GABA(A), and/or alpha(5)GABA(A) subtypes. Our results also suggest that the alpha(1)GABA(A) receptor subtype might be critically involved in the subjective, sedative, and motor effects of benzodiazepine-type drugs. In contrast, stimulation of alpha(1)GABA(A) receptors is sufficient, but not necessary, for mediation of the abuse potential of these drugs.